Nature CommunicationsCell BiologyPeer-reviewed journal article
Trajectory analysis of hepatic stellate cell differentiation reveals metabolic regulation of cell commitment and fibrosis
Raquel A. Martínez García de la TorreiD, Júlia VallverdúiD, Zhixin XuiD, Sílvia AriñoiD, Raquel Ferrer‐LorenteiD, Laura Zanatto, María Mercado-GómeziD, Beatriz Aguilar‐Bravo, Paloma Ruiz-BlázqueziD, M. Guadalupe Fernández, Artur Navarro‐Gascon, Albert Blasco‐RosetiD, Paula Sànchez‐Fernàndez‐de‐LandaiD, Joan PeraiD, Damià Romero–MoyaiD, Paula Ayuso GarciaiD, Celia Martínez–SáncheziD, Laura Sererols-ViñasiD, Paula Cantallops VilàiD, Carmen Cárcamo Giráldez, Andrew McQuilliniD, Marsha Yvonne MorganiD, Daniel Moya-RulliD, Núria MontserratiD, Delphine EberléiD, , Pau Sancho‐BruiD
Abstract
Defining the trajectory of cells during differentiation and disease offers the possibility to understand the mechanisms driving cell fate and identity. However, trajectories of human cells are largely unexplored. By investigating the proteome trajectory of iPSCs differentiation to hepatic stellate cells (dHSCs), we identified RORA as a key transcription factor governing the metabolic reprogramming of HSCs necessary for HSCs commitment, identity, and activation. Using RORA deficient iPSCs and pharmacologic interventions, we showed that RORA is required for mesoderm differentiation and prevents dHSCs activation by reducing the high energetic state of the cells. While RORA knockout mice had enhanced fibrosis, RORA agonists rescued multi- organ fibrosis in in vivo models. RORA expression was consistently found to be negatively correlated with liver fibrosis and HSCs activation markers in patients with liver disease. This study reveals that RORA regulates cell metabolic plasticity, crucial for mesoderm differentiation, pericyte quiescence, and fibrosis, influencing cell commitment and disease mechanisms. SummaryThis study describes the trajectory of induced pluripotent stem cells (iPSCs) differentiation to hepatic stellate cells (dHSCs). We identify RAR-related orphan receptor alpha (RORA) as a transcription factor essential for mesoderm commitment and dHSCs identity and fibrogenic activation by regulating metabolic plasticity.
- organism: mouse
- organism: human
- assay: proteomics
- assay: multiome
- research focus: cell type annotation
- research focus: trajectory inference
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: deep learning
- approach: statistical model
- Citations
- 23
- FWCI
- 8.38
- Field percentile
- top 1%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Vorinostat Can Reduce an Ongoing Fibrosis and Preserve Key Liver Metabolic Functions by Selectively Altering Mesenchymal Cell Differentiation
YUAN GUAN, Gary Peltz·bioRxiv·Nov 4, 2026
- Hepatic stellate cells drive hypoxia-inducible factor (HIF)-dependent metabolic rewiring and proliferation in hepatocellular carcinoma cells
Demi J. Rijlaarsdam, Jung‐Chin Chang, … Celia R. Berkers·bioRxiv·Oct 28, 2026
- Hepatic stellate cell FXR signaling regulates context-dependent functions in liver homeostasis and fibrosis.
Manjula Vinod, Francesco Paolo Zummo, … Alexandre Berthier·bioRxiv·Aug 31, 2026
- A rule-based multiscale model of hepatic stellate cell plasticity: critical role of the inactivation loop in fibrosis progression
Matthieu Bouguéon, Vincent Legagneux, … Nathalie Théret·PLoS Computational BiologyPeer-reviewed·Jul 29, 2024
- PPARgamma, a key modulator of metabolic reprogramming, stemness and chemoresistance associated with retrodifferentiation in human hepatocellular carcinomas
Yoann Daniel, Claudine Rauch, … Anne Corlu·Cell Death and DiseasePeer-reviewed·Nov 17, 2025
- Development of a high throughput system to screen compounds that revert the activated hepatic stellate cells to a quiescent-like state